vs
Side-by-side financial comparison of Core Scientific, Inc. (CORZ) and Viridian Therapeutics, Inc.\DE (VRDN). Click either name above to swap in a different company.
Core Scientific, Inc. is the larger business by last-quarter revenue ($79.8M vs $70.6M, roughly 1.1× Viridian Therapeutics, Inc.\DE). Core Scientific, Inc. runs the higher net margin — 268.5% vs -49.0%, a 317.5% gap on every dollar of revenue. On growth, Viridian Therapeutics, Inc.\DE posted the faster year-over-year revenue change (81958.1% vs -16.0%). Viridian Therapeutics, Inc.\DE produced more free cash flow last quarter ($-84.7M vs $-450.8M).
Core Scientific is a leading digital asset and high-performance computing infrastructure provider. It operates large energy-efficient data centers across North America, offering cryptocurrency mining services, colocation hosting for blockchain and AI clients, and custom high-performance computing solutions for enterprise tech segments.
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.
CORZ vs VRDN — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $79.8M | $70.6M |
| Net Profit | $214.2M | $-34.6M |
| Gross Margin | 26.0% | — |
| Operating Margin | -149.5% | -56.7% |
| Net Margin | 268.5% | -49.0% |
| Revenue YoY | -16.0% | 81958.1% |
| Net Profit YoY | 180.6% | 54.9% |
| EPS (diluted) | $-1.63 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $79.8M | — | ||
| Q3 25 | $81.1M | $70.6M | ||
| Q2 25 | $78.6M | — | ||
| Q1 25 | $79.5M | — | ||
| Q4 24 | $94.9M | — | ||
| Q3 24 | $95.4M | — | ||
| Q2 24 | $141.1M | — | ||
| Q1 24 | $179.3M | — |
| Q4 25 | $214.2M | — | ||
| Q3 25 | $-144.0M | $-34.6M | ||
| Q2 25 | $-936.8M | — | ||
| Q1 25 | $576.3M | — | ||
| Q4 24 | $-265.5M | — | ||
| Q3 24 | $-455.3M | — | ||
| Q2 24 | $-902.2M | — | ||
| Q1 24 | $210.7M | — |
| Q4 25 | 26.0% | — | ||
| Q3 25 | 4.8% | — | ||
| Q2 25 | 6.4% | — | ||
| Q1 25 | 10.3% | — | ||
| Q4 24 | 5.0% | — | ||
| Q3 24 | -0.2% | — | ||
| Q2 24 | 27.5% | — | ||
| Q1 24 | 43.3% | — |
| Q4 25 | -149.5% | — | ||
| Q3 25 | -67.6% | -56.7% | ||
| Q2 25 | -33.4% | — | ||
| Q1 25 | -59.1% | — | ||
| Q4 24 | -41.9% | — | ||
| Q3 24 | -43.2% | — | ||
| Q2 24 | -64.3% | — | ||
| Q1 24 | 30.8% | — |
| Q4 25 | 268.5% | — | ||
| Q3 25 | -177.6% | -49.0% | ||
| Q2 25 | -1191.4% | — | ||
| Q1 25 | 724.6% | — | ||
| Q4 24 | -279.7% | — | ||
| Q3 24 | -477.4% | — | ||
| Q2 24 | -639.4% | — | ||
| Q1 24 | 117.5% | — |
| Q4 25 | $-1.63 | — | ||
| Q3 25 | $-0.45 | — | ||
| Q2 25 | $-0.04 | — | ||
| Q1 25 | $1.24 | — | ||
| Q4 24 | $0.51 | — | ||
| Q3 24 | $-1.17 | — | ||
| Q2 24 | $-5.05 | — | ||
| Q1 24 | $0.78 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $311.4M | $490.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-962.7M | $503.0M |
| Total Assets | $2.3B | $577.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $311.4M | — | ||
| Q3 25 | $453.4M | $490.9M | ||
| Q2 25 | $581.3M | — | ||
| Q1 25 | $697.9M | — | ||
| Q4 24 | $836.2M | — | ||
| Q3 24 | $253.0M | — | ||
| Q2 24 | $96.1M | — | ||
| Q1 24 | $98.1M | — |
| Q4 25 | $-962.7M | — | ||
| Q3 25 | $-1.3B | $503.0M | ||
| Q2 25 | $-1.2B | — | ||
| Q1 25 | $-308.8M | — | ||
| Q4 24 | $-943.0M | — | ||
| Q3 24 | $-826.7M | — | ||
| Q2 24 | $-1.2B | — | ||
| Q1 24 | $-318.5M | — |
| Q4 25 | $2.3B | — | ||
| Q3 25 | $2.2B | $577.1M | ||
| Q2 25 | $1.9B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | $824.6M | — | ||
| Q2 24 | $664.2M | — | ||
| Q1 24 | $814.0M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $278.3M | $-84.6M |
| Free Cash FlowOCF − Capex | $-450.8M | $-84.7M |
| FCF MarginFCF / Revenue | -565.1% | -120.1% |
| Capex IntensityCapex / Revenue | 914.0% | 0.2% |
| Cash ConversionOCF / Net Profit | 1.30× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-779.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $278.3M | — | ||
| Q3 25 | $131.8M | $-84.6M | ||
| Q2 25 | $34.0M | — | ||
| Q1 25 | $-45.0M | — | ||
| Q4 24 | $42.9M | — | ||
| Q3 24 | $5.7M | — | ||
| Q2 24 | $1.2M | — | ||
| Q1 24 | $22.2M | — |
| Q4 25 | $-450.8M | — | ||
| Q3 25 | $-112.7M | $-84.7M | ||
| Q2 25 | $-87.3M | — | ||
| Q1 25 | $-129.0M | — | ||
| Q4 24 | $-52.1M | — | ||
| Q3 24 | $-25.5M | — | ||
| Q2 24 | $-1.9M | — | ||
| Q1 24 | $-9.7M | — |
| Q4 25 | -565.1% | — | ||
| Q3 25 | -139.0% | -120.1% | ||
| Q2 25 | -111.0% | — | ||
| Q1 25 | -162.2% | — | ||
| Q4 24 | -54.8% | — | ||
| Q3 24 | -26.7% | — | ||
| Q2 24 | -1.4% | — | ||
| Q1 24 | -5.4% | — |
| Q4 25 | 914.0% | — | ||
| Q3 25 | 301.5% | 0.2% | ||
| Q2 25 | 154.2% | — | ||
| Q1 25 | 105.6% | — | ||
| Q4 24 | 100.0% | — | ||
| Q3 24 | 32.7% | — | ||
| Q2 24 | 2.2% | — | ||
| Q1 24 | 17.8% | — |
| Q4 25 | 1.30× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -0.08× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.11× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CORZ
| Other | $36.3M | 46% |
| Digital Asset Self Mining Service | $31.8M | 40% |
| Colocation Service | $11.6M | 15% |
VRDN
Segment breakdown not available.
